LATEST ALERTS
Cosmic Fog Vapors is the latest e-cig independent to come into the fold of Big Tobacco, with Fontem Ventures, a subsidiary of Imperial Brands, acquiring a minority stake in the company
The massive criticism directed at the Foundation for a Smoke-Free World (FSFW) has not kept it from working with the best scientists in the field, according to its founder and president Derek Yach
The e-cigarette industry could support the case for flavours – currently strongly associated in regulators’ minds with an appeal to youth – by changing its marketing strategies, according to Chris Howard of E-Alternative Solutions
Seven public health groups have brought a suit against the US Food and Drug Administration for extending deadlines for e-cigs and cigars on its controversial deeming regulations
More than a third of US vapers buy their devices exclusively over the counter in vape stores – even though it’s cheaper to buy the same products online
The US Food and Drug Administration (FDA), concerned about flavours leading youth to start vaping, has issued an advance notice of proposed rulemaking (ANPRM) to explore options for regulation
Language changing the “grandfathering date” for vaping products has been dropped from the US Appropriations Bill as the government hurries again to avoid another shutdown
More than half of US consumers wrongly believe that using nicotine every day is more dangerous than drinking every day, according to a new global survey from the Foundation for a Smoke-free World (FSFW)
A new study examining vaping’s impact on US smoking rates has gained widespread media coverage for its suggestion that e-cigarettes will create more new smokers
The US FDA has taken a step closer to regulating nicotine levels in combustible cigarettes, but excluded vapour products from its proposals, even predicting a low-nicotine regime might encourage smokers toward electronic alternatives
In our latest report on developments in the legal cannabis market, ECigIntelligence considers whether PMI may be setting up a future move in that direction. We also look at the potential dangers of synthetic cannabis products
The launch of a new anti-tobacco watchdog organisation, STOP, will increase the divide between those who welcome tobacco industry involvement in reduced-risk alternatives and those who want Big Tobacco excluded from the debate
A letter from conservative groups in the US begs Republican leaders to adopt a version of the Cole-Bishop amendment in the final omnibus appropriations package for the fiscal year 2018
Canadian MPs have moved to toughen proposed restrictions on the advertising of e-cigarettes as Canada prepares its first law to regulate the vaping industry at national level
There may be widespread disregard of US FDA rules around the introduction of new vapour products and a new inspection regime may have its hands full, ECigIntelligence research suggests
British American Tobacco (BAT) has announced it will invest half the money it has saved from US corporate tax restructuring in next generation products
The US FDA recognises flavoured e-liquids may help encourage smokers to switch to e-cigs, despite its hostility to flavours in most tobacco products, commissioner Scott Gottlieb told the Society for Research on Nicotine & Tobacco (SRNT)
The US FDA has made some public amendments to PMI’s reduced risk applications for IQOS and three types of Marlboro HeatSticks products
The federal health minister for Canada has called for “clear restrictions” on e-cigarette advertising and the need to keep young people from taking up e-cigs. The move is a turnaround from the stance of the previous health minister.
British American Tobacco claims to be the largest reduced-risk product company in the world following its acquisition of Reynolds American and says it will build on this through a variety of HnB, moist tobacco and oral tobacco brands
Top executives of Philip Morris International (PMI) have promised at a major US analysts’ conference to make the raw data from clinical and non-clinical studies for the company’s reduced risk products available to the public later this year
The most common reason that youth used e-cigs in the US in 2016 was that a friend or family member used them, according to information from the National Youth Survey for 2016, analysis of which was recently published by the Center for Disease Control and Prevention (CDC). The second most-prevalent was the availability of flavours.
The libertarian Pacific Legal Foundation (PLF) has brought a series of suits from vape stores across the US to several federal district courts, alleging that the FDA’s deeming rule violates the US Constitution
Ten US Senators have urged the FDA to reject PMI’s reduced risk application for IQOS following the findings of the independent Tobacco Products Scientific Advisory Committee (TPSAC)
The furore stirred up last year by the news agency Reuters’ coverage of Philip Morris International (PMI) has now died down, but it may have impacted on the company in three distinct ways
The abrupt resignation of Brenda Fitzgerald as director of the Centers for Disease Control and Prevention could provide the Trump administration with an unexpected opportunity to help settle a question on the agency’s anti-tobacco efforts
A widely publicised New York report concludes that e-cig “smoke…may contribute to lung and bladder cancer, as well as heart disease, in humans” – but other scientists question the validity of research carried out on laboratory mice
The US government has been given an ‘F’ grade by the American Lung Association for its federal tobacco regulations and taxation policies, blaming its “partial implementation” of the Tobacco Control Act
The Hawaiian senate is considering two bills, which could prohibit online sales of e-cigarette products if passed. One could also subject e-liquids to the same excise tax as tobacco products.
A report by the US National Academies of Sciences, Engineering, and Medicine (NASEM) presents a long list of suggestions for research into the public health consequences of e-cigarettes
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.
By signing up you agree to our Terms and Conditions Please note trial access may take up to 24 hours to be granted as access must be qualified by a member of the ECigIntelligence team.
